Published in Eur J Neurol on April 14, 2013
The attenuation of retinal nerve fiber layer thickness and cognitive deterioration. Front Cell Neurosci (2013) 0.83
Improvement of oxidative and metabolic parameters by cellfood administration in patients affected by neurodegenerative diseases on chelation treatment. Biomed Res Int (2014) 0.76
High spatial resolution imaging mass spectrometry of human optic nerve lipids and proteins. J Am Soc Mass Spectrom (2015) 0.76
Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients. J Lipid Res (2015) 0.76
Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS. Neurology (2011) 5.16
Venous angioplasty in patients with multiple sclerosis: results of a pilot study. Eur J Vasc Endovasc Surg (2011) 4.68
Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis. Neurology (2011) 3.62
Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N Engl J Med (1983) 2.91
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology (2004) 2.50
Aerial dissemination of pulmonary tuberculosis. A two-year study of contagion in a tuberculosis ward. 1959. Am J Epidemiol (1995) 2.40
MRI findings in Susac's syndrome. Neurology (2003) 2.17
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL. Neurology (2007) 2.17
Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG) Neurology (1998) 2.16
Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA (1994) 2.14
A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients. Am J Kidney Dis (1999) 2.07
Abnormal vergence with upper brainstem infarcts: pseudoabducens palsy. Neurology (2000) 2.04
Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test. Mult Scler (2007) 1.99
Cost-effectiveness of disease-modifying therapy for multiple sclerosis: a population-based study. Neurology (2011) 1.89
Thalamic atrophy and cognition in multiple sclerosis. Neurology (2007) 1.87
Eight-year follow-up study of brain atrophy in patients with MS. Neurology (2002) 1.78
Identification of information flow-modulating drug targets: a novel bridging paradigm for drug discovery. Clin Pharmacol Ther (2008) 1.77
Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions. Anal Biochem (1986) 1.75
A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients. Clin Nephrol (1999) 1.71
Risk factors of multiple sclerosis: a case-control study. Neurol Sci (2003) 1.68
The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is related to altered cerebrospinal fluid dynamics. Funct Neurol (2009) 1.62
Prevention of ultraviolet-light-induced herpes labialis by sunscreen. Lancet (1991) 1.60
Increased tissue damage and lesion volumes in African Americans with multiple sclerosis. Neurology (2010) 1.58
Endovascular ruptured abdominal aortic aneurysm repair (EVRAR): a systematic review. Eur J Vasc Endovasc Surg (2007) 1.56
Optimization of specimen-handling procedures for accurate quantitation of levels of human immunodeficiency virus RNA in plasma by reverse transcriptase PCR. J Clin Microbiol (1998) 1.53
A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosis. Neurology (1998) 1.52
Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. Brain (2009) 1.50
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology (2007) 1.45
Antihyperglycemic activity of phenolics from Pterocarpus marsupium. J Nat Prod (1997) 1.44
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology (2005) 1.43
Improved method for i.r. determination of the degree of N-acetylation of chitosan. Int J Biol Macromol (1992) 1.38
Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test. Mult Scler (2009) 1.38
Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome. J Infect Dis (1998) 1.37
Animal models in experimental diabetes mellitus. Indian J Exp Biol (1997) 1.27
Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler (2006) 1.26
Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol (2012) 1.24
Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis. Mult Scler (2003) 1.24
Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis (1993) 1.21
Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J Neurol (2001) 1.20
Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry (2008) 1.19
Reference values of pulmonary diffusing capacity during exercise by a rebreathing technique. Am J Respir Crit Care Med (1995) 1.16
Comparison of three different methods for measurement of cervical cord atrophy in multiple sclerosis. AJNR Am J Neuroradiol (2007) 1.15
A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis. Clin Nephrol (2007) 1.14
Infarction of the optic nerve head in children with accelerated hypertension. Br J Ophthalmol (1981) 1.13
Interpreting patient/informant discrepancies of reported cognitive symptoms in MS. J Int Neuropsychol Soc (2005) 1.13
Gorham's disease: a case (including dental presentation) of vanishing bone disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2000) 1.13
Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups. Mult Scler (1999) 1.13
Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS. Mult Scler (2009) 1.11
Gray matter pathology in (chronic) MS: modern views on an early observation. J Neurol Sci (2009) 1.11
Familial and environmental risk factors in Parkinson's disease: a case-control study in north-east Italy. Acta Neurol Scand (2002) 1.11
Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants. J Infect Dis (1994) 1.10
The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev (1998) 1.10
Rapid disease course in African Americans with multiple sclerosis. Neurology (2010) 1.10
Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study. Mult Scler (2010) 1.10
In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects. J Neuroimmunol (2001) 1.09
An assessment of microbiological water quality of six water source categories in north-east Uganda. J Water Health (2010) 1.09
Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS. Neurology (2001) 1.08
MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis. J Neurol Sci (2005) 1.08
Management of multiple sclerosis. N Engl J Med (1997) 1.08
Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients. Mult Scler (2000) 1.07
Multiple sclerosis gender issues: clinical practices of women neurologists. Mult Scler (2004) 1.07
Diversity and plasticity of self recognition during the development of multiple sclerosis. J Clin Invest (1997) 1.07
Rapid detection of Serpulina hyodysenteriae in diagnostic specimens by PCR. J Clin Microbiol (1994) 1.06
Value of MR venography for detection of internal jugular vein anomalies in multiple sclerosis: a pilot longitudinal study. AJNR Am J Neuroradiol (2011) 1.05
Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis. Arch Neurol (2006) 1.05
Compensatory alveolar growth normalizes gas-exchange function in immature dogs after pneumonectomy. J Appl Physiol (1985) (1999) 1.05
Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis. Eur J Neurol (2005) 1.05
Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry (2009) 1.04
Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study. Int Angiol (2010) 1.03
Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire. Mult Scler (2008) 1.03
Hypoglycemic activity of Nymphaea stellata leaves ethanolic extract in alloxan induced diabetic rats. Fitoterapia (2007) 1.02
Intra- and extraluminal structural and functional venous anomalies in multiple sclerosis, as evidenced by 2 noninvasive imaging techniques. AJNR Am J Neuroradiol (2011) 1.02
Clinical features of children and adolescents with multiple sclerosis. Neurology (2007) 1.02
Elaboration of the matrix glycoprotein of enamel by the secretory ameloblasts of the rat incisor as revealed by radioautography after galactose- 3 H injection. J Cell Biol (1971) 1.01
Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia. Med Microbiol Immunol (2004) 1.01
Cardiopulmonary adaptations to pneumonectomy in dogs. IV. Membrane diffusing capacity and capillary blood volume. J Appl Physiol (1985) (1994) 1.01
Cardiopulmonary adaptations to pneumonectomy in dogs. II. VA/Q relationships and microvascular recruitment. J Appl Physiol (1985) (1993) 1.01
Preventing mediastinal shift after pneumonectomy does not abolish physiological compensation. J Appl Physiol (1985) (2000) 1.01
Single-dose pharmacokinetics and tolerance of a cholesteryl sulfate complex of amphotericin B administered to healthy volunteers. Antimicrob Agents Chemother (1991) 1.00
Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis. Am J Gastroenterol (2002) 0.99
Sexual dysfunction in multiple sclerosis: a 2-year follow-up study. J Neurol Sci (2001) 0.98
The role of thymectomy in red cell aplasia. Ann Thorac Surg (1979) 0.98
Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. J Reprod Immunol (1997) 0.97
Cardiac output during exercise measured by acetylene rebreathing, thermodilution, and Fick techniques. J Appl Physiol (1985) (1995) 0.97
Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onset. Mult Scler (2009) 0.96